NewsBenzinga인모드, 2026회계연도 조정 주당순이익 가이던스 1.29~1.34달러로 확정 (컨센서스 1.30달러) 및 매출 가이던스 3억 6,500만~3억 7,500만 달러로 확정 (컨센서스 3억 7,032만 8천 달러) 인모드, 2026회계연도 조정 주당순이익 가이던스 1.29~1.34달러로 확정 (컨센서스 1.30달러) 및 매출 가이던스 3억 6,500만~3억 7,500만 달러로 확정 (컨센서스 3억 7,032만 8천 달러) Benzinga 2026.11.11 12:01 (GMT+0) Open on Benzinga Other news Global-E Online Stock Is Falling Wednesday: What's Going On? Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6 Stifel Maintains Buy on Ecolab, Raises Price Target to $356 Stifel Upgrades Tandem Diabetes Care to Buy, Raises Price Target to $26 Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients
Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease
Immuneering Presents Preclinical Data Demonstrating Potential Of Atebimetinib; Phase 2 Results Include Long Survival And Outstanding Tolerability Profile In First-Line Pancreatic Cancer Patients